ArticleBreast cancer (Tokyo, Japan)2025

Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy.

Masayuki Nagahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.